entertainment -WSS

entertainment

author：Wikipedia 2025-10-02 22:12:46 - browse：113

A caretaker speaks with an elderly Alzheimer's patient at a nursing home. — ALAIN JOCARD/AFP via Getty Images

For more than 30 years, Alzheimer’s researchers have thought of APOE4 as a major genetic risk factor for most cases of the devastating neurologic disease. But a new study published on Monday argues that this gene variant plays an even more important role than scientists had realized and causes a distinct form of Alzheimer’s.

Researchers analyzed data from more than 13,000 people, including nearly 800 APOE4 homozygotes, people who carry two copies of the gene variant. They found that nearly all of the homozygotes showed biological signs of Alzheimer’s in the brain, and they typically developed dementia and other symptoms, and died sooner, than people with Alzheimer’s who lack APOE4.

The research team also found that APOE4 homozygotes showed a predictable pattern of biomarker changes linked to Alzheimer’s, including a buildup of beta-amyloid and tau, a protein linked to neuron damage and death.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Childbirth

WSS

iTeos Therapeutics debuts first data on TIGIT

Insmed lung disease drug hits target in key Phase 3 trial

Latest bird flu infection made farmworker sicker than earlier cases

FDA gives detailed accounting of AI

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Hospital price transparency does save money, advocate argues

hotspot

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Wikipedia

Activists slam private health insurers over coverage restrictions

Eli Lilly expects to double planned employment in Boston center

As demand for Covid shots wanes, Moderna seeks its next success

HHS leader on health, climate change and biopharma emissions

Medical leaders decry Supreme Court decision on affirmative action

Will Ozempic

Apple is now the first public company to be valued at $3 trillion

Studies point to risks of excluding people with obesity from drug trials

Virginia high school admissions case could be legal follow

HHS leader on health, climate change and biopharma emissions

focus

Solve the antibiotic resistance crisis with preventive drugs

Addiction doctors spar with methadone clinics over legislation

How climate

Focused ultrasound for uterine fibroids: an uphill battle

FDA struggles to regulate food additives, sometimes for decades

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

focus

leisure time

hotspot

hotspot